LDLR and B-cell non-Hodgkin lymphoma: DCA and OXPHOS also increased LDLR mRNA and protein as well as LDL intake in primary lymphoma cells derived from a B cell lymphoma patient (BCL-P2; Fig. 1A, Supplemental Fig. 1B and Fig. 1E).